The scientific rationale for pairing peptides with distinct but non-overlapping mechanisms is well-established in pharmacology research
One area that has attracted academic discussion, press coverage, and significant biotechnology/pharma R&D investment is concern about undesirable, collateral skeletal muscle mass (SMM) loss, and presumably by extension, loss of strength and function in people taking GLP-1 medications
After adjusting for calendar time, health system, age, ancestry, and baseline weight, female sex remained significantly associated with higher rates of BMI loss (p=0.021)
The schedule exists for a reason
February 26, 2025 - In-Home Screenings--Provider Referral Process Thank you for being a valued provider for members in one or more of our health plans: Health Partners Plans Medicaid, Health Partners Plans CHIP, Jefferson Health Plans Medicare Advantage, and/or Jefferson Health Plans Individual and Family Plans